Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Revive Therapeutics Ltd. C.RVV

Alternate Symbol(s):  RVVTF

Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of therapeutics for rare disorders and infectious diseases. The Company is exploring the use of Bucillamine for the treatment of infectious diseases, with an initial focus on severe influenza and COVID-19. Through its subsidiary, Psilocin Pharma Corp., the Company is advancing the development of Psilocybin-based therapeutics in various diseases and disorders. The Company’s cannabinoid pharmaceutical portfolio focuses on rare inflammatory diseases and the Company was granted Food and Drug Administration (FDA) orphan drug status designation for the use of Cannabidiol (CBD) to treat autoimmune hepatitis (liver disease) and to treat ischemia and reperfusion injury from organ transplantation.


CSE:RVV - Post by User

Post by fumperbunon Jul 01, 2020 8:27pm
201 Views
Post# 31213781

Psilocybin

PsilocybinThis company is using psilocybin to treat mental disorders as well as the bucillamine as a potential treatment for lung problems.

Totally legit and investors are looking for investments in psychedelics.

That is why this stock is going crazy and there is no real reason for it to stop rising while waiting for confirmation on the phase 3 study.

Call it what you want but this company could easily go as high as shrm did at almost 3 dollars over a short period of time.

I can see this at over a buck easily based on what i saw shrm do and the fact that bucillamine could very well go into phase 3 trials.

Now if this does go into phase 3 trials and there is no real reason why it won't.

Well then we are definitely going into the mulitiple dollar status.

And if the trials prove successful........ Yikessss.............

And this stock is trading under .50 cents.

The fact alone it could take days or weeks for confirmation tells me the worse case scenario is it rises until the announcement.

Me Likey this company.
<< Previous
Bullboard Posts
Next >>